An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study

CME Part II: Immune checkpoint inhibitor-related dermatologic adverse events

(2020) Amaris N. Geisler et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy

(2020) Chiemi Hirose et al.   SUPPORTIVE CARE IN CANCER

Adverse cutaneous reactions to chemotherapeutic drugs

(2020) Dylan Haynes et al.   CLINICS IN DERMATOLOGY

Cutaneous adverse events in patients receiving anticancer therapy in a tertiary hospital setting: the old and the new

(2020) Hae‐Jin Suh et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Management of skin adverse reactions in oncology

(2020) Diva Silva et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

An Emollient Containing Aquaphilus dolomiae Extract is Effective in the Management of Xerosis and Pruritus: An International, Real-World Study

(2020) Mette Deleuran et al.   Dermatology and Therapy

Dermatological side effects of targeted antineoplastic therapies: a prospective study

(2020) Senay Agirgol et al.   Cutaneous and Ocular Toxicology

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, And Management Guidelines

(2020) Mario E. Lacouture et al.   ONCOLOGIST

Prophylaxis and Management of Skin Toxicities

(2019) Martin Salzmann et al.   Breast Care

Prevalence, Predictors and Comorbidity of Dry Skin in the General Population

(2018) M. Augustin et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

(2018) A. Wollenberg et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails

(2018) Mario Lacouture et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

(2018) C. Grávalos et al.   Clinical & Translational Oncology

Skin adverse events in recently approved targeted therapies in solid malignancies

(2018) Maya Habre et al.   Future Oncology

Regression of cutaneous xerosis with emollient treatment in sub-Saharan African patients

(2017) Franck Boralevi et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional Study

(2017) Jaewon Lee et al.   Cancer Research and Treatment

Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors

(2016) R.-D. Hofheinz et al.   ONCOLOGIST

Effects of a New Emollient-Based Treatment on Skin Microflora Balance and Barrier Function in Children with Mild Atopic Dermatitis

(2016) Pascale Bianchi et al.   PEDIATRIC DERMATOLOGY

Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery

(2015) Kenji Sekiguchi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Incidence and risk of xerosis with targeted anticancer therapies

(2015) Johannah Valentine et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Moisturizers are effective in the treatment of xerosis irrespectively from their particular formulation: results from a prospective, randomized, double-blind controlled trial

(2015) J.H. Shim et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Xerosis and pruritus as major EGFRI-associated adverse events

(2015) Julia M. K. Clabbers et al.   SUPPORTIVE CARE IN CANCER

Visual Analogue Scale: Evaluation of the Instrument for the Assess­ment of Pruritus

(2013) A Reich et al.   ACTA DERMATO-VENEREOLOGICA

Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic

(2013) Alyx C. Rosen et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams

(2013) Eva Ulff et al.   RADIOTHERAPY AND ONCOLOGY

Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel

(2013) Rene Jean Bensadoun et al.   Cancer Management and Research

Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm

(2012) Z. Reguiai et al.   SUPPORTIVE CARE IN CANCER

Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer

(2010) Mario E. Lacouture et al.   JOURNAL OF CLINICAL ONCOLOGY

Skin care management in cancer patients: an evaluation of quality of life and tolerability

(2010) Ann Cameron Haley et al.   SUPPORTIVE CARE IN CANCER